Medical Properties Trust INC Stock: price and directors' dealings · United States · SEC (Form 4)Track the Medical Properties Trust INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Real Estate sector, Medical Properties Trust INC has published 190 insider filings. Market capitalisation: €2.4bn. The latest transaction was reported on 20 August 2026 (Acquisition). Among the most active insiders: Hanna James Kevin. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Medical Properties Trust INC Hold (neutral), based on 7 analysts. Average price target: US$5.11.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
All Executives190 Thresholds0 Prospectus0 Other0
Declarations 190 total
▲ Senior VP, Controller & CAO · Executives · 20 Aug 2026
2,300 shares @ US$4.15 Common stock, par value $0.001 SEC:0001193125-26-359423:0
Canonical exit: 18 Nov 2026 (T+90) ● SVP of Finance and Treasurer · Executives · 8 Jul 2026
2,347 shares @ US$4.61 0.0004% mcap 36.5% of flow Common stock, par value $0.001 SEC:0001193125-26-298833:0
● Chairman, President & CEO · Executives · 8 Jul 2026
109,433 shares @ US$4.61 0.019% mcap 2.6% of flow Common stock, par value $0.001 SEC:0001193125-26-298832:0
● Executive Vice President & CFO · Executives · 8 Jul 2026
48,548 shares @ US$4.61 0.0084% mcap 2.7% of flow Common stock, par value $0.001 SEC:0001193125-26-298829:0
● Senior VP, Controller & CAO · Executives · 8 Jul 2026
3,295 shares @ US$4.61 0.0006% mcap 5.0% of flow Common stock, par value $0.001 SEC:0001193125-26-298831:0
● SVP of Operations · Executives · 8 Jul 2026
1,938 shares @ US$4.61 0.0003% mcap 50.2% of flow Common stock, par value $0.001 SEC:0001193125-26-298828:0
● SVP, Senior Advisor to the CEO · Executives · 8 Jul 2026
4,048 shares @ US$4.61 0.0007% mcap 9.5% of flow Common stock, par value $0.001 SEC:0001193125-26-298830:0
● Chairman, President & CEO · Executives · 8 Apr 2026
109,433 shares @ US$4.67 2.7% of flow Common stock, par value $0.001 SEC:0001193125-26-148528:0
● Executive Vice President & CFO · Executives · 8 Apr 2026
48,548 shares @ US$4.67 2.8% of flow Common stock, par value $0.001 SEC:0001193125-26-148527:0
● SVP, Senior Advisor to the CEO · Executives · 8 Apr 2026
4,048 shares @ US$4.67 10.4% of flow Common stock, par value $0.001 SEC:0001193125-26-148526:0
● Senior VP, Controller & CAO · Executives · 8 Apr 2026
3,295 shares @ US$4.67 5.3% of flow Common stock, par value $0.001 SEC:0001193125-26-148523:0
● SVP of Finance and Treasurer · Executives · 8 Apr 2026
2,347 shares @ US$4.67 57.0% of flow Common stock, par value $0.001 SEC:0001193125-26-148525:0
● SVP of Operations · Executives · 8 Apr 2026
1,938 shares @ US$4.67 100.0% of flow Common stock, par value $0.001 SEC:0001193125-26-148524:0
◆ SVP, Senior Advisor to the CEO · Executives · 18 Mar 2026
75,000 shares 0Common stock, par value $0.001 SEC:0001969950-26-000004:0
◆ SVP of Operations · Executives · 18 Mar 2026
42,500 shares 0Common stock, par value $0.001 SEC:0001969905-26-000004:0
◆ Senior VP, Controller & CAO · Executives · 18 Mar 2026
75,000 shares 0Common stock, par value $0.001 SEC:0001665881-26-000004:0
◆ SVP of Finance and Treasurer · Executives · 18 Mar 2026
50,000 shares 0Common stock, par value $0.001 SEC:0001225492-26-000004:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009190:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009188:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009187:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009186:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009185:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009183:0
◆ Director · Executives · 8 Jan 2026
30,303 shares 0Common stock, par value $0.001 SEC:0001193125-26-009182:0
◆ Executive Vice President & CFO · Executives · 8 Jan 2026
509,124 shares 0Common stock, par value $0.001 SEC:0001193125-26-009137:0
25 of 190 declarations
Load more (165 remaining) 关于 Medical Properties Trust INC Medical Properties Trust, Inc. (NYSE: MPT) 是一家在美国纽约证券交易所上市的公司,总部位于美国阿拉巴马州伯明翰。MPT 成立于2003年,围绕一个专注的房地产理念建立:收购和开发医院设施,并根据长期净租赁结构将其租赁给医疗保健运营商。这使得 MPT 成为一家专业的医疗保健房地产投资信托基金,而不是医疗服务运营商。因此,其盈利模式主要由合同租金收入、资产管理、资本配置及其租户的信用质量驱动。
公司的核心业务围绕医院房地产所有权、售后回租交易、物业收购、以医疗保健资产为担保的融资解决方案以及选择性投资组合再循环。随着时间的推移,MPT 已从普通急性护理医院扩展到行为健康和后期护理设施。这种更广泛的组合为投资组合提供了一些运营多元化,尽管该业务仍然高度受租户表现、报销压力和医院运营商财务状况的影响。在竞争方面,MPT 是全球最知名的医院业主之一,拥有执行大型复杂交易的规模和专业化能力。其利基专业知识是一个重要优势,但也带来了比多元化房地产投资信托基金更具特殊性的风险状况。
MPT 不生产医疗产品,也不提供临床护理。其“产品”是资本和房地产解决方案:长期租赁、结构化融资、售后回租以及以医院为重点的物业所有权。这种专业化是公司的主要差异化因素,因为医院融资需要对医疗保健运营、监管环境和资本密集度有深入了解。医院通常需要大量的持续投资,这支持了对像 MPT 这样的专业房地产资本提供商的长期需求。
在地理上,MPT 历史上建立了一个跨国平台,在美国和几个国际市场拥有物业。这种足迹提供了多元化,但也带来了跨境执行、监管和货币方面的考量。公司最近的披露强调了持续积极的投资组合管理、债务和流动性纪律以及资本再循环。
最近值得关注的发展包括公司品牌重塑和纽约证券交易所股票代码从 MPW 更改为 MPT,自2026年2月2日起生效,以及发布2026年第一季度业绩和宣布每股0.09美元的季度股息。管理层评论还强调了持续努力管理租户相关风险、变现选定投资和加强资产负债表。对于国际股票投资者而言,MPT 仍然是一家高度专业化的医疗保健房地产投资信托基金,具有独特的风险回报特征:结构上暴露于重要的医院基础设施,但也暴露于租户集中度、再融资条件和运营商特定压力。